Diacerein is a medicine that is used to relieve pain, stiffness and swelling of joints associated with osteoarthritis.

Osteoarthritis is a joint disorder caused when the protective cartilage which acts as a cushion between two ends of bones wears down, leading to joint tenderness and pain with movement.

It works by forming a soft connective tissue around the joints (cartilage), thus it relieves pain and swelling at the joints.

Material Safety Data Sheet

SECTION 1 – CHEMICAL PRODUCT AND COMPANY IDENTIFICATION

 

MSDS Identification Name            : Diacerein

Supplier                                      :  ATILUS PHARMA PVT. LTD.

 

SECTION 2 – COMPOSITION, INFORMATION ON INGREDIENTS

CAS  No. :  13739-02-1

Chemical Name : 1,8-Diacetoxy-3-carboxyanthraquinone

Synonyms                      :  1,8-Diacetoxy-3-carboxyanthraquinone

Formula                         :  C19H12O8

Molecular weight            :  368,29 g/mol

 

SECTION 3 – HAZARDS IDENTIFICATION

3.1 Classification of the substance or mixture

Classification according to Regulation (EC) No 1272/2008

Skin irritation (Category 2), H315

Eye irritation (Category 2), H319

Specific target organ toxicity – single exposure (Category 3), Respiratory system, H335

For the full text of the H-Statements mentioned in this Section, see Section 16.

3.2 Label elements

Labelling according Regulation (EC) No 1272/2008

Hazard statement(s)

H315 Causes skin irritation.

H319 Causes serious eye irritation.

H335 May cause respiratory irritation.

Precautionary statement(s)

P261 Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray.

P264 Wash skin thoroughly after handling.

P271 Use only outdoors or in a well-ventilated area.

P280 Wear protective gloves/ eye protection/ face protection.

P302 + P352 IF ON SKIN: Wash with plenty of water.

P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes.

Remove contact lenses, if present and easy to do. Continue rinsing.

Supplemental Hazard

Statements

None

Other hazards

This substance/mixture contains no components considered to be either persistent,

bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at

levels of 0.1% or higher.

Ecological information:

The substance/mixture does not contain components considered to have endocrine

disrupting properties according to REACH Article 57(f) or Commission Delegated regulation

(EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

Toxicological information:

The substance/mixture does not contain components considered to have endocrine

disrupting properties according to REACH Article 57(f) or Commission Delegated regulation

(EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

 

SECTION 4 – FIRST AID MEASURES

4.1 Description of first-aid measures

General advice

Consult a physician. Show this material safety data sheet to the doctor in attendance.

If inhaled

If breathed in, move person into fresh air. If not breathing, give artificial respiration.

Consult a physician.

In case of skin contact

Wash off with soap and plenty of water. Consult a physician.

In case of eye contact

Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.

If swallowed

Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult

a physician.

4.2 Most important symptoms and effects, both acute and delayed

The most important known symptoms and effects are described in the labelling (see section

2.2) and/or in section 11

4.3 Indication of any immediate medical attention and special treatment needed

No data available

 

SECTION 5 – FIRE FIGHTING MEASURES

5.1 Extinguishing media

Suitable extinguishing media

Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.

5.2 Special hazards arising from the substance or mixture

Carbon oxides

5.3 Advice for firefighters

Wear self-contained breathing apparatus for firefighting if necessary.

5.4 Further information

No data available

 

SECTION 6 – ACCIDENTAL RELEASE MEASURES

6.1 Personal precautions, protective equipment and emergency procedures

Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or

gas. Ensure adequate ventilation. Evacuate personnel to safe areas. Avoid breathing dust.

For personal protection see section 8.

6.2 Environmental precautions

Do not let product enter drains.

6.3 Methods and materials for containment and cleaning up

Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in

suitable, closed containers for disposal.

6.4 Reference to other sections

For disposal see section 13.

 

SECTION 7 – HANDLING AND STORAGE

7.1 Precautions for safe handling

Advice on safe handling

Avoid contact with skin and eyes. Avoid formation of dust and aerosols.

Advice on protection against fire and explosion

Provide appropriate exhaust ventilation at places where dust is formed.

Hygiene measures

Handle in accordance with good industrial hygiene and safety practice. Wash hands before

breaks and at the end of workday.

For precautions see section 2.2.

7.2 Conditions for safe storage, including any incompatibilities

Storage conditions

Keep container tightly closed in a dry and well-ventilated place. Store in cool place.

Storage class

Storage class (TRGS 510): 11: Combustible Solids

7.3 Specific end use(s)

Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

 

SECTION 8 – EXPOSURE CONTROLS, PERSONAL PROTECTION

8.1 Control parameters

Ingredients with workplace control parameters

8.2 Exposure controls

Personal protective equipment

Eye/face protection

Safety glasses with side-shields conforming to EN166 Use equipment for eye

protection tested and approved under appropriate government standards such as

NIOSH (US) or EN 166(EU).

Skin protection

Handle with gloves. Gloves must be inspected prior to use. Use proper glove

removal technique (without touching glove’s outer surface) to avoid skin contact

with this product. Dispose of contaminated gloves after use in accordance with

applicable laws and good laboratory practices. Wash and dry hands.

The selected protective gloves have to satisfy the specifications of Regulation (EU)

2016/425 and the standard EN 374 derived from it.

Body Protection

Impervious clothing, The type of protective equipment must be selected according

to the concentration and amount of the dangerous substance at the specific

workplace.

Respiratory protection

For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle

respirator.For higher level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU

EN 143) respirator cartridges. Use respirators and components tested and approved

under appropriate government standards such as NIOSH (US) or CEN (EU).

Control of environmental exposure

Do not let product enter drains.

 

SECTION 9 – PHYSICAL AND CHEMICAL PROPERTIES

9.1 Information on basic physical and chemical properties

 

  1. a) Appearance Form : Solid
  2. b) Odor                  : Not applicable
  3. c) Odor                   : Not applicable
  4. d) pH : No data available
  5. e) Melting point/freezing point Melting point/range: No data available
  6. f) Autoignition :No data available

temperature

  1. g) Decomposition temperature :No data available
  2. h) Viscosity Viscosity, kinematic : No data available

Viscosity, dynamic                      : No data available

  1. i) Explosive properties : No data available
  2. j) Oxidizing properties :No data available

 

9.2 Other safety information

No data available

 

SECTION 10 – STABILITY AND REACTIVITY

10.1 Reactivity

No data available

10.2 Chemical stability

Stable under recommended storage conditions.

10.3 Possibility of hazardous reactions

No data available

10.4 Conditions to avoid

No data available

10.5 Incompatible materials

Strong oxidizing agents

10.6 Hazardous decomposition products

In the event of fire: see section 5

 

SECTION 11 – TOXICOLOGICAL INFORMATION

11.1 Information on toxicological effects

Acute toxicity

Oral: No data available

Inhalation: No data available

Dermal: No data available

Skin corrosion/irritation

Remarks: No data available

Serious eye damage/eye irritation

Remarks: No data available

Respiratory or skin sensitization

No data available

Germ cell mutagenicity

No data available

Carcinogenicity

No data available

Reproductive toxicity

No data available

Specific target organ toxicity – single exposure

Inhalation – May cause respiratory irritation.

Specific target organ toxicity – repeated exposure

No data available

Aspiration hazard

No data available

11.2 Additional Information

Endocrine disrupting properties

Product:

Assessment : The substance/mixture does not contain

components considered to have endocrine

disrupting properties according to REACH Article

57(f) or Commission Delegated regulation (EU)

2017/2100 or Commission Regulation (EU)

2018/605 at levels of 0.1% or higher.

 

SECTION 12 – ECOLOGICAL INFORMATION

12.1 Toxicity

No data available

12.2 Persistence and degradability

No data available

12.3 Bioaccumulative potential

No data available

12.4 Mobility in soil

No data available

12.5 Results of PBT and vPvB assessment

This substance/mixture contains no components considered to be either persistent,

bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at

levels of 0.1% or higher.

12.6 Endocrine disrupting properties

Product:

Assessment : The substance/mixture does not contain components

considered to have endocrine disrupting properties

according to REACH Article 57(f) or Commission

Delegated regulation (EU) 2017/2100 or Commission

Regulation (EU) 2018/605 at levels of 0.1% or higher.

12.7 Other adverse effects

No data available

 

SECTION 13 – DISPOSAL CONSIDERATIONS

13.1 Waste treatment methods

Product

Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or

mix the material with a combustible solvent and burn in a chemical incinerator equipped

with an afterburner and scrubber. Waste material must be disposed of in accordance with

the Directive on waste 2008/98/EC as well as other national and local regulations. Leave

chemicals in original containers. No mixing with other waste. Handle uncleaned containers

like the product itself.

Contaminated packaging

Dispose of as unused product.

 

SECTION 14 – TRANSPORT INFORMATION

14.1 UN number

ADR/RID: – IMDG: – IATA: –

14.2 UN proper shipping name

ADR/RID: Not dangerous goods

IMDG: Not dangerous goods

IATA: Not dangerous goods

14.3 Transport hazard class(es)

ADR/RID: – IMDG: – IATA: –

14.4 Packaging group

ADR/RID: – IMDG: – IATA: –

14.5 Environmental hazards

ADR/RID: no IMDG Marine pollutant: no IATA: no

14.6 Special precautions for user

No data available

Further information

Not classified as dangerous in the meaning of transport regulations.

 

SECTION 15 – REGULATORY INFORMATION

15.1 Safety, health and environmental regulations/legislation specific for the

substance or mixture

This material safety data sheet complies with the requirements of Regulation (EC) No.

1907/2006.

15.2 Chemical Safety Assessment

For this product a chemical safety assessment was not carried out

 

SECTION 16 – ADDITIONAL INFORMATION

The information above is believed to be accurate and represents the best information currently available to us. However, we make no warranty of merchantability or any other warranty, express or implied, with respect to such information, and we assume no liability resulting from its use. Users should make their own investigations to determine the suitability of the information for their particular purposes. In no way shall the company be liable for any claims, losses, or damages of any third party or for lost profits or any special, indirect, incidental, consequential or exemplary damages, howsoever arising, even if the company has been advised of the possibility of such damages.

WhatsApp
+91 9819994077
India Copyrights © 2024 Atilus Pharma All right reserved.
Primetech Nxt
Developed By Primetech NXT